UNSPSC 51334201: Clorotepine

This classification denotes a dopamine antagonist with the molecular formula C19H21ClN2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E65W20MU7A, chemically known as 1-(8-chloro-10,11-dihydrodibenzo(b,f)thiepin-10-yl)-4-methylpiperazine but generally known as clorotepine, which bears US NIH Compound Identifier 1238. European Medicines Agency schedules Clorotepine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06765MIG. The term CLOROTEPINE is an International Non-Proprietary Name.

UNSPSC 51334201 Clorotepine is a Commodity code that captures pharmaceutical procurement by state and local health agencies, though the recent solicitation activity under this code tag does not reflect clorotepine itself but rather naloxone and drug deactivation systems acquired for community health and opioid-response initiatives. State and local governments are using this code space to procure life-safety pharmaceutical products and associated medical equipment on a recurring, competitively bid basis. County health departments and public health authorities represent the primary issuing bodies, with procurement structured around annual or multi-year supply agreements that include delivery and storage requirements at specific facilities.

Seminole County, Florida posted the only recent opportunity in the source: IFB60459723LAS, an Invitation for Bid released June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 and quarterly delivery to the Seminole County Community Health Building in Sanford. The procurement is structured as a two-year initial term with one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and carries potential FEMA funding with attendant federal environmental compliance obligations. The code shows limited recent activity in the source record, concentrated in Florida.